RESUMEN
Sickle cell disease (SCD) and thalassaemia are genetic disorders that are caused by errors in the genes for haemoglobin and are some of the most common significant genetic disorders in the world, resulting in significant morbidity and mortality. Great disparities exist in the outcome of these conditions between resource- rich and resource-poor nations. Antenatal screening for these disorders aims to provide couples with information about their reproductive risk and enable them to make informed reproductive choices; ultimately reducing the likelihood of children being born with these conditions. This review provides an overview of the current status of antenatal, pre-marital and population screening of SCD and thalassaemia in countries with both high-and low prevalence of these conditions, methods of screening in use, and discusses some of the pitfalls, ethical issues and controversies surrounding antenatal screening. It also discusses outcomes of some screening programmes and recognises the need for the establishment of antenatal screening in areas where their prevalence is highest; namely sub-Saharan Africa and India.
Asunto(s)
Hemoglobinopatías/diagnóstico , Diagnóstico Prenatal/métodos , Anemia de Células Falciformes/diagnóstico , Anemia de Células Falciformes/epidemiología , Femenino , Humanos , Embarazo , Diagnóstico Prenatal/ética , Diagnóstico Prenatal/normas , Talasemia/diagnóstico , Talasemia/epidemiologíaRESUMEN
BACKGROUND: Children with sickle cell disease (SCD) often have obstructive lung function abnormalities which could be due to asthma or increased pulmonary blood volume; it is important to determine the underlying mechanism to direct appropriate treatment. In asthmatics, exhaled nitric oxide (FeNO) is elevated. FeNO, however, can also be raised due to increased alveolar production. Our aim, therefore, was to determine if airway or alveolar NO production differed between SCD children and ethnic and age-matched controls. METHODS: Lung function, airway NO flux and alveolar NO production, and effective pulmonary blood flow were assessed in 18 SCD children and 18 ethnic and age-matched controls. RESULTS: The SCD children compared to the controls had a higher respiratory system resistance (P = 0.0008), alveolar NO production (P = 0.0224), and pulmonary blood flow (P < 0.0001), but not airway NO flux. There was no significant correlation between FeNO and respiratory system resistance in either group, but in the SCD children, there were correlations between alveolar NO production (P = 0.0006) and concentration (P < 0.0001) and pulmonary blood flow. CONCLUSION: Airway NO flux was not elevated in the SCD children nor correlated with airways obstruction, suggesting that airways obstruction, at least in some SCD children, is not due to asthma.
Asunto(s)
Obstrucción de las Vías Aéreas/etiología , Resistencia de las Vías Respiratorias , Anemia de Células Falciformes/complicaciones , Pulmón/metabolismo , Óxido Nítrico/metabolismo , Circulación Pulmonar , Adolescente , Obstrucción de las Vías Aéreas/diagnóstico , Obstrucción de las Vías Aéreas/metabolismo , Obstrucción de las Vías Aéreas/fisiopatología , Anemia de Células Falciformes/diagnóstico , Biomarcadores/metabolismo , Velocidad del Flujo Sanguíneo , Pruebas Respiratorias , Estudios de Casos y Controles , Niño , Femenino , Humanos , Pulmón/irrigación sanguínea , Pulmón/fisiopatología , Masculino , Pruebas de Función Respiratoria , Factores de RiesgoRESUMEN
Sickle cell disease (SCD) is characterized by vasculopathy, which has been causally linked to intravascular haemolysis and high levels of free plasma haemoglobin. Soluble CD163 (sCD163) is implicated in the clearance of free plasma haemoglobin and high plasma concentrations have been linked to arterial disease. We therefore investigated the value of sCD163 as a biomarker in children with SCD, and also measured haptoglobin levels in this population. We measured sCD163 in 25 control children with no haemoglobinopathy, 41 with sickle cell anaemia (HbSS) in the steady state, 27 with HbSS taking hydroxycarbamide, and 7 with HbSC disease. There was no significant difference between sCD163 levels in steady-state HbSS (1·78 mg/l) and controls (1·81 mg/l) (P = 0·86). However, sCD163 levels were significantly lower in those HbSS children taking hydroxycarbamide (1·35 mg/l) compared to both steady state HbSS (P = 0·004) and controls (P = 0·036). In children on hydroxycarbamide, sCD163 correlated negatively and highly significantly with percentage HbF (R = -0·76, P < 0·001), and this relationship was absent in those not taking hydroxycarbamide (R = 0·07, P = 0·65). sCD163 is a potentially useful biomarker in children with SCD, and may have a role in monitoring responses to hydroxycarbamide.
Asunto(s)
Anemia de Células Falciformes/sangre , Antígenos CD/sangre , Antígenos de Diferenciación Mielomonocítica/sangre , Receptores de Superficie Celular/sangre , Adolescente , Anemia de Células Falciformes/tratamiento farmacológico , Antidrepanocíticos/uso terapéutico , Biomarcadores/sangre , Estudios de Casos y Controles , Niño , Preescolar , Monitoreo de Drogas/métodos , Femenino , Haptoglobinas/metabolismo , Hemólisis , Humanos , Hidroxiurea/uso terapéutico , Masculino , SolubilidadRESUMEN
A study published in 1981 examined the causes of hospital admission for a cohort of children with sickle cell disease (SCD). Since that time, the incidence and prevalence of SCD has increased markedly in the UK, and there have been many changes in the management of this disease. We undertook a study examining the causes of hospital admission of children with SCD to the same hospital as the previous study, over the 2-year period from 2008 to 2009. We found that the numbers of children being cared for by our hospital had dramatically increased over the last 50 years, but rates of hospital admission had significantly fallen (41 hospital admissions per 100 patient-years, compared with 111.3 admissions per 100 patient-years in the original study). This fall in admission rates is accounted for by 2 major components: acute painful episodes (15.7 admissions per 100 patient-years compared with 39.3 in the previous study) and admission for elective blood transfusion (0.2 admissions per 100 patient-years compared with 26.7 in the previous study). It is interesting to note that, 541 elective transfusions were carried out during the study period, but in a day-care setting rather than requiring overnight admission. This study illustrates the changes in management of SCD over the past 30 years, and reflects the overall trend common to most hospital specialties of increasing community and ambulatory care.
Asunto(s)
Anemia de Células Falciformes/epidemiología , Hospitalización/estadística & datos numéricos , Anemia de Células Falciformes/patología , Anemia de Células Falciformes/terapia , Transfusión Sanguínea , Estudios de Cohortes , Femenino , Humanos , MasculinoRESUMEN
We retrospectively audited children with sickle cell disease (SCD) admitted to paediatric intensive care (PICU) at King's College Hospital between January 2000 and December 2008. Forty-six children with SCD were admitted, on 49 separate occasions. Ages ranged from 4 months to 15 years (median 7.6 years). Three children died in PICU, however two presented to hospital in cardiorespiratory arrest; overall mortality was 6%. The most common reason for admission was acute chest syndrome (43%). 88% of admissions required blood transfusion, of which 74% had exchange blood transfusions. The mortality among children with SCD admitted to PICU is low.
Asunto(s)
Anemia de Células Falciformes/terapia , Cuidados Críticos/métodos , Síndrome Torácico Agudo/etiología , Adolescente , Anemia de Células Falciformes/complicaciones , Antibacterianos/uso terapéutico , Transfusión Sanguínea , Cardiotónicos/uso terapéutico , Niño , Preescolar , Hospitalización , Humanos , Lactante , Unidades de Cuidado Intensivo Pediátrico , Tiempo de Internación/estadística & datos numéricos , Respiración Artificial , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
Low nocturnal oxygen saturation (SpO(2)) is implicated in complications of Sickle Cell Anemia (SCA). Twenty-four children with SCA were randomized to receive overnight auto-adjusting continuous positive airway pressure (auto-CPAP) with supplemental oxygen, if required, to maintain SpO(2) >or=94% or as controls. We assessed adherence, safety, sleep parameters, cognition and pain. Twelve participants randomized to auto-CPAP (3 with oxygen) showed improvement in Apnea/Hypopnea Index (p<0.001), average desaturation events >3%/hour (p=0.02), mean nocturnal SpO(2) (p=0.02) and cognition. Primary efficacy endpoint (Processing Speed Index) showed no group differences (p=0.67), but a second measure of processing speed and attention (Cancellation) improved in those receiving treatment (p=0.01). No bone marrow suppression, rebound pain or serious adverse event resulting from auto-CPAP use was observed. Six weeks of auto-CPAP therapy is feasible and safe in children with SCA, significantly improving sleep-related breathing disorders and at least one aspect of cognition.
Asunto(s)
Anemia de Células Falciformes/fisiopatología , Anemia de Células Falciformes/terapia , Presión de las Vías Aéreas Positiva Contínua/métodos , Adolescente , Niño , Eritrocitos/metabolismo , Femenino , Humanos , Masculino , Pruebas Neuropsicológicas , Oxígeno/metabolismo , Cooperación del Paciente , Polisomnografía/métodos , Calidad de Vida , Sueño , Resultado del TratamientoRESUMEN
Sickle cell anaemia (SCA; HbSS) is characterised by its clinical variability, which is only partly explained by known genetic factors. Environmental factors are known to contribute to acute problems but their importance in chronic complications has not been analysed. We have studied 93 children with SCA in a single institution, who underwent transcranial Doppler scanning and steady-state blood tests in 2006. These data were correlated with each individual's exposure to pollution from dust (PM(10)), nitric oxide (NO) and nitrogen dioxide (NO(2)). This exposure was derived from patient postcodes and detailed street-level maps of average pollutant levels in 2006. All the pollutants correlated closely with each other. Increased exposure to pollution correlated with a significant reduction in total bilirubin levels, with a trend towards lower levels of lactate dehydrogenase and aspartate transaminase. There was significant correlation between extracranial internal carotid artery blood velocity and PM(10) exposure. These studies suggest that chronic exposure to air pollutants could explain some variability in SCA. The lower levels of bilirubin and other markers of haemolysis with increased exposure to air pollutants could be mediated by increased exposure to NO.
Asunto(s)
Contaminantes Atmosféricos/efectos adversos , Contaminación del Aire/efectos adversos , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/patología , Adolescente , Contaminantes Atmosféricos/análisis , Contaminación del Aire/análisis , Anemia de Células Falciformes/enzimología , Niño , Preescolar , Femenino , Humanos , MasculinoRESUMEN
Cerebrovascular disease resulting in stroke is a serious and preventable complication of sickle cell anaemia (SCA). Children at high risk of preventable stroke can be identified by transcranial Doppler ultrasound (TCD). Current guidelines in the UK recommend annual TCD screening from 3 years, although studies suggest an earlier peak incidence, between 2 and 5 years. A single centre retrospective review was undertaken to identify the prevalence of stroke and success of TCD screening in young children. We report five episodes of stroke in under 3s and outcome of TCD screening in children under 3, compared to over 3. TCD analysis was as successful in the 2-3-year age group as in the 3-4-year group. We therefore propose that all children with SCA should be offered TCD screening from the age of 2 years. Furthermore, infants with high risk features of SCA should undergo a first attempt at TCD screening even earlier.
Asunto(s)
Anemia de Células Falciformes/complicaciones , Accidente Cerebrovascular/prevención & control , Preescolar , Humanos , Lactante , Prevalencia , Estudios Retrospectivos , Accidente Cerebrovascular/diagnóstico por imagen , Accidente Cerebrovascular/etiología , Ultrasonografía Doppler TranscranealRESUMEN
Serum lactate dehydrogenase (LDH) levels were studied in children with HbSS and HbSC in a single institution, and their relationship to cerebral vasculopathy as assessed by transcranial Doppler scanning (TCD). All children with HbSS (n = 97) and HbSC (n = 18) who underwent a TCD scan in 2006 were studied. LDH levels were higher in HbSS patients than HbSC (581 IU/l vs. 305 IU/l, P < 0.001). In children with HbSS, LDH correlated significantly with haemoglobin, reticulocytes, aspartate transaminase and creatinine. LDH also correlated positively and significantly with TCD measurements in the middle and anterior cerebral artery circulations in the children with HbSS.
Asunto(s)
Anemia de Células Falciformes/diagnóstico , L-Lactato Deshidrogenasa/sangre , Adolescente , Anemia de Células Falciformes/diagnóstico por imagen , Anemia de Células Falciformes/fisiopatología , Biomarcadores/sangre , Circulación Cerebrovascular , Niño , Preescolar , Pruebas Enzimáticas Clínicas/métodos , Femenino , Enfermedad de la Hemoglobina SC/diagnóstico , Enfermedad de la Hemoglobina SC/diagnóstico por imagen , Enfermedad de la Hemoglobina SC/fisiopatología , Hospitalización , Humanos , Masculino , Ultrasonografía Doppler TranscranealAsunto(s)
Anemia de Células Falciformes/terapia , Transfusión Sanguínea , Trastornos Cerebrovasculares/etiología , Hidroxiurea/uso terapéutico , Adolescente , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/complicaciones , Anemia de Células Falciformes/tratamiento farmacológico , Isquemia Encefálica/etiología , Isquemia Encefálica/prevención & control , Infarto Cerebral/etiología , Infarto Cerebral/prevención & control , Revascularización Cerebral , Trastornos Cerebrovasculares/tratamiento farmacológico , Trastornos Cerebrovasculares/prevención & control , Trastornos Cerebrovasculares/cirugía , Trastornos Cerebrovasculares/terapia , Niño , Terapia Combinada , Progresión de la Enfermedad , Femenino , Hemoglobinas/análisis , Humanos , Hidroxiurea/efectos adversos , Recuento de Leucocitos , Masculino , Enfermedad de Moyamoya/etiología , Enfermedad de Moyamoya/terapia , Estudios Retrospectivos , Prevención Secundaria , Reacción a la TransfusiónRESUMEN
OBJECTIVE: To evaluate England's NHS newborn sickle cell screening programme performance in children up to the age of 5 years. DESIGN: Cohort of resident infants with sickle cell disease (SCD) born between 1 September 2010 and 31 August 2015 and followed until August 2016. PARTICIPANTS: 1317 infants with SCD were notified to the study from all centres in England and 1313 (99%) were followed up. INTERVENTIONS: Early enrolment in clinical follow-up, parental education and routine penicillin prophylaxis. MAIN OUTCOME MEASURES: Age seen by a specialist clinician, age at prescription of penicillin prophylaxis and mortality. RESULTS: All but two resident cases of SCD were identified through screening; one baby was enrolled in care after prenatal diagnosis; one baby whose parents refused newborn screening presented symptomatically. There were 1054/1313 (80.3%, 95% CI 78% to 82.4%) SCD cases seen by a specialist by 3 months of age and 1273/1313 (97%, 95% CI 95.9% to 97.8%) by 6 months. The percentage seen by 3 months increased from 77% in 2010 to 85.4% in 2015. 1038/1292 (80.3%, 95% CI 78.1% to 82.5%) were prescribed penicillin by 3 months of age and 1257/1292 (97.3%, 95% CI 96.3% to 98.1%) by 6 months. There were three SCD deaths <5 years caused by invasive pneumococcal disease (IPD) sensitive to penicillin. CONCLUSION: The SCD screening programme is effective at detecting affected infants. Enrolment into specialist care is timely but below the programme standards. Mortality is reducing but adherence to antibiotic prophylaxis remains important for IPD serotypes not in the current vaccine schedule.
Asunto(s)
Anemia de Células Falciformes/diagnóstico , Tamizaje Neonatal/normas , Factores de Edad , Anemia de Células Falciformes/epidemiología , Antibacterianos/uso terapéutico , Profilaxis Antibiótica/estadística & datos numéricos , Inglaterra/epidemiología , Educación en Salud/estadística & datos numéricos , Investigación sobre Servicios de Salud/métodos , Humanos , Recién Nacido , Cumplimiento de la Medicación/estadística & datos numéricos , Tamizaje Neonatal/métodos , Tamizaje Neonatal/organización & administración , Padres/educación , Penicilinas/uso terapéutico , Evaluación de Programas y Proyectos de Salud , Medicina Estatal/organización & administración , Medicina Estatal/normasRESUMEN
OBJECTIVE: To describe the clinical presentation, risk factors, serotype distribution and outcomes of invasive pneumococcal disease (IPD) in children with sickle cell disease (SCD) following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in the UK. DESIGN: Prospective national newborn screening for SCD and enhanced national IPD surveillance. PARTICIPANTS: Children with SCD born in England between 1 September 2010 and 31 August 2014 who developed laboratory-confirmed IPD by 31 December 2015. MAIN OUTCOMES AND MEASURES: Risk of IPD in children with SCD compared with children without SCD during the surveillance period. RESULTS: Eleven children homozygote for haemoglobin S (HbSS) and one double heterozygote for haemoglobin S and C (HbSC) developed IPD. Septicaemia (n=7) and lower respiratory tract infection (n=4) were the main clinical presentations, and serogroup 15 (not present in PCV13) was responsible for 73% (8/11) of cases. Three children with HbSS (27%) died compared with <5% nationally. Children with HbSS had a 49-fold (95% CI 27 to 89, P<0.001) higher risk of IPD compared with their peers without SCD. CONCLUSIONS: Children with SCD remain at increased risk of IPD despite national newborn screening, early penicillin prophylaxis and high pneumococcal vaccine uptake. They are also more likely to die of their infection compared with their peers without SCD. Most IPD cases are now due to serotypes not covered by PCV13. Healthcare professionals need to work more closely with families with SCD and local communities to emphasise the importance of penicillin prophylaxis, explore barriers, allay misguided beliefs and facilitate rapid access to healthcare.
Asunto(s)
Anemia de Células Falciformes/complicaciones , Infecciones Oportunistas/complicaciones , Infecciones Neumocócicas/complicaciones , Anemia de Células Falciformes/diagnóstico , Anemia de Células Falciformes/epidemiología , Estudios de Cohortes , Inglaterra/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Tamizaje Neonatal , Infecciones Oportunistas/epidemiología , Infecciones Oportunistas/prevención & control , Infecciones Neumocócicas/epidemiología , Infecciones Neumocócicas/prevención & control , Vacunas Neumococicas , Prevalencia , Infecciones del Sistema Respiratorio/complicaciones , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/prevención & control , Factores de Riesgo , Sepsis/complicaciones , Sepsis/epidemiología , Sepsis/prevención & control , Gales/epidemiologíaRESUMEN
OBJECTIVES: To prospectively assess longitudinal lung function in children with sickle cell disease (SCD). WORKING HYPOTHESIS: Lung function in SCD children deteriorates with increasing age and the decline is more marked in younger children who have recently suffered ACS episodes. STUDY DESIGN: Two prospective longitudinal studies. PATIENT-SUBJECT SELECTION: Two cohorts of SCD children and age and ethnic matched controls were recruited. Cohort One (47 SCD and 26 controls) had a median age of 8.8 years and follow up of 2 years and Cohort Two (45 SCD and 26 controls) a median age of 10.2 years and follow up of 10 years. METHODOLOGY: Forced expiratory volume in one second (FEV1 ), vital capacity (VC), forced expiratory flow between 25% and 75% of VC (FEF 25-75 ), total lung capacity (TLC) and residual volume (RV) were measured on two occasions. RESULTS: In both groups of SCD children, lung function declined significantly, but in neither control group. ACS episodes were more frequent during the follow up period in Cohort One than Cohort Two (P < 0.0001). The rate of decline was greater in Cohort One than Cohort Two for FEV1 (P = 0.008), VC (P = 0.001), FEF25-75 (P = 0.030), TLC (P = 0.004), and RV (P = 0.043). In Cohort Two restrictive abnormalities were more common at follow up (P = 0.006). CONCLUSIONS: Lung function deteriorated with increasing age in SCD children and the rate of decline was greater in younger children in whom ACS episodes were more common. Pediatr Pulmonol. 2016;51:717-723. © 2015 Wiley Periodicals, Inc.
Asunto(s)
Anemia de Células Falciformes/fisiopatología , Pulmón/fisiopatología , Adolescente , Anemia de Células Falciformes/epidemiología , Niño , Preescolar , Femenino , Volumen Espiratorio Forzado , Humanos , Masculino , Flujo Espiratorio Medio Máximo , Estudios Prospectivos , Capacidad Pulmonar TotalRESUMEN
Sickle cell disease (SCD) comprises a group of recessively inherited blood disorders and is the most common genetic disorder in the world (Embury et al., 1994). It is a chronic condition of variable severity that mainly affects people of African and African-Caribbean heritage. Over the last 20 years life expectancy has increased significantly, particularly for patients receiving western healthcare so that increasing attention has been directed to the psychosocial adaptation and neurocognitive profile of children and adolescents with SCD. Previously, research suggested that, like children with other chronic health conditions, children and adolescents with SCD were at increased risk for emotional and behavioural disorders. More recent research has not demonstrated increased rates of such difficulties. Increasing evidence suggests that children with severe disease are, however, at significantly increased risk for cerebro-vascular events and neurocognitive difficulties. This paper reviews the literature regarding the psychological and neurocognitive functioning of children with SCD and outlines a number of ways that psychological input may significantly contribute to more effective health care for these children and their families.
RESUMEN
OBJECTIVES AND WORKING HYPOTHESIS: Airways obstruction occurs in young children with sickle cell disease (SCD). Our aim was to test the hypothesis that increased pulmonary capillary blood volume at least in part explained the increased airways obstruction as this would inform which therapy might be most appropriate to treat the airway obstruction. STUDY DESIGN: Observational study. PATIENT-SUBJECT SELECTION: Twenty-five SCD children and 25 ethnic origin matched controls were recruited. METHODOLOGY: Respiratory system resistance, using impulse oscillometry at 5 Hz (R5 %pred), pulmonary capillary blood volume (Vc), alveolar volume (VA), and spirometry were assessed before and after bronchodilator (ipratropium bromide). Lung volume measurements were also made. RESULTS: The SCD children compared to the controls had a higher R5 %pred before (median 133 (range 88-181)% vs. 102 (83-184)%, P = 0.0046) and after (105 (79-150)% vs. 91 (64-147)%, P = 0.0489) bronchodilator and their median Vc/VA (ml/L) was higher before (26 (18-38) vs. 18 (14-28) P < 0.0001) and after (26 (19-41) vs. 18 (13-27) P < 0.0001) bronchodilator. There were similar decreases in R5 %pred post-bronchodilator in the two groups, but no significant changes in Vc/VA in either group. Vc/VA correlated significantly with R5 %pred in the SCD children only. CONCLUSIONS: Increased pulmonary capillary blood volume contributes to the increased airways obstruction in children with SCD, hence, bronchodilators may be of limited benefit in reducing their airways obstruction.
Asunto(s)
Obstrucción de las Vías Aéreas/etiología , Anemia de Células Falciformes/fisiopatología , Volumen Sanguíneo , Capilares/fisiopatología , Pulmón/irrigación sanguínea , Adolescente , Obstrucción de las Vías Aéreas/fisiopatología , Volumen Sanguíneo/efectos de los fármacos , Broncodilatadores/administración & dosificación , Broncodilatadores/farmacología , Capilares/efectos de los fármacos , Estudios de Casos y Controles , Niño , Femenino , Volumen Espiratorio Forzado/efectos de los fármacos , Humanos , Pulmón/efectos de los fármacos , Pulmón/fisiopatología , Mediciones del Volumen Pulmonar , Masculino , Oscilometría , Espirometría , Capacidad Vital/efectos de los fármacosRESUMEN
Peripheral venous access in children with sickle cell anaemia (SCA) requiring regular blood transfusions can become difficult over time. Previous reports have suggested the use of totally implantable venous access devices, Portacaths (PAC) in this patient group are associated with unacceptable high rates of complications. We present our experience in seven children with SCA over a 9-year period. Seven devices were placed for a total of 9754 PAC days during the study period. The median age at insertion was 6.3 years (range 3-15 years). The rate of PAC associated infection was 0.2 per 1000 PAC days. There were no episodes of thrombosis. The median length of time in situ during the study period was 3.7 years (range 1.3-7.5 years). Our experience highlights the safe and reliable use of PAC in children with SCA requiring regular blood transfusions when venous access has become a major problem.
Asunto(s)
Anemia de Células Falciformes/terapia , Catéteres de Permanencia/efectos adversos , Transfusión de Eritrocitos/instrumentación , Adolescente , Infecciones Relacionadas con Catéteres/etiología , Cateterismo Venoso Central/efectos adversos , Cateterismo Venoso Central/instrumentación , Niño , Preescolar , Remoción de Dispositivos , Falla de Equipo , Femenino , Humanos , Masculino , Auditoría Médica , Trombosis/etiologíaRESUMEN
OBJECTIVE: To assess the role of transcranial Doppler (TCD) scanning in assessing the risk of stroke in children with haemoglobin SC (HbSC) disease. TCD scanning has an established role in primary stroke prevention in sickle cell anaemia but its value in HbSC is unknown. DESIGN: A retrospective audit of routinely performed TCD scans and routinely collected clinical data. SETTING: A paediatric sickle cell clinic in a teaching hospital in south London, UK. PATIENTS: 46 children with HbSC disease who have undergone routinely performed TCD scans and steady-state blood tests. MAIN OUTCOME MEASURES: The time-averaged mean of the maximum velocity (TAMMV) in the middle cerebral artery circulation correlated with clinical and laboratory data. RESULTS: The mean TAMMV was 94 cm/s, with a 98(th) centile of 128 cm/s. This is significantly less than the published ranges for HbSS, with a mean reading of 129 cm/s. One child had a stroke at the age of 5 years, when her TAMMV was measured at 146 cm/s. CONCLUSIONS: Further studies are needed to assess stroke risk in HbSC disease, but we suggest that TCD measurements are potentially useful in this condition, and that readings greater than 128 cm/s are abnormally high and warrant further investigation.
Asunto(s)
Anemia de Células Falciformes/complicaciones , Anemia de Células Falciformes/diagnóstico por imagen , Accidente Cerebrovascular/etiología , Adolescente , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/fisiopatología , Velocidad del Flujo Sanguíneo , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Arteria Cerebral Media/diagnóstico por imagen , Arteria Cerebral Media/fisiopatología , Recuento de Plaquetas , Estudios Retrospectivos , Medición de Riesgo/métodos , Accidente Cerebrovascular/diagnóstico por imagen , Accidente Cerebrovascular/fisiopatología , Ultrasonografía Doppler Transcraneal/métodosRESUMEN
OBJECTIVE: Increased intracerebral blood velocity measured by transcranial Doppler scanning identifies children with sickle cell anemia who are at increased risk of stroke. We have tried to develop an index based on routine clinical measurements that also predicts increased intracerebral blood flow. METHOD: Routinely collected clinical and laboratory data were correlated with transcranial Doppler measurements on children with sickle cell anemia seen in a single institution in 2006. The index produced was validated on a second independent data set from children with sickle cell anemia. RESULTS: The time-averaged mean of the maximum velocity in centimeters per second in the middle cerebral artery circulation correlated significantly with age, hemoglobin, lactate dehydrogenase, and aspartate transaminase levels, white blood cell count, and creatinine level. On multiple regression, hemoglobin and aspartate transaminase levels maintained their significance, whereas age had borderline significance, and an index was developed linked to a time-averaged mean of the maximum velocity of 220 - (8 x hemoglobin) - (1.4 x age) + (0.4 x aspartate transaminase). This detected a time-averaged mean of the maximum velocity of >170 cm/second with 100% sensitivity and 58% specificity. The index was validated on the second data set and again showed 100% sensitivity with 73% specificity. CONCLUSION: This simple index has the potential to identify children who are at higher risk of cerebrovascular disease to allow them to be prioritized for transcranial Doppler scanning and other intracerebral imaging.
Asunto(s)
Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/fisiopatología , Aspartato Aminotransferasas/sangre , Circulación Cerebrovascular , Hemoglobinas/análisis , Ultrasonografía Doppler Transcraneal , Adolescente , Factores de Edad , Niño , Preescolar , Humanos , Valor Predictivo de las PruebasRESUMEN
The clinical severity of sickle-cell disease (SCD) is dependent on genetic and environmental variables. Environmental factors have been poorly studied. We have investigated possible links between air pollution and acute pain in SCD. We retrospectively studied the numbers of daily admissions with acute sickle-cell pain to King's College Hospital, London, in relation to local daily air quality measurements. We analysed 1047 admissions over 1400 d (1st January 1998-31st October 2001). Time series analysis was performed using the cross-correlation function (CCF). CCF showed a significant association between increased numbers of admissions and low levels of nitric oxide (NO), low levels of carbon monoxide (CO) and high levels of ozone (O(3)). There was no association with sulphur dioxide (SO(2)), nitrogen dioxide or PM(10) (dust). The significant results were further examined using quartile analysis. This confirmed that high levels of O(3) and low levels of CO were associated with increased numbers of hospital admissions. Low NO levels were also associated with increased admissions but did not reach statistical significance on quartile analysis. Our study suggests air quality has a significant effect on acute pain in SCD and that patients should be counselled accordingly. The potential beneficial effect of CO and NO is intriguing and requires further investigation.